To view the Scientific Programme from the 2017 congress please click here

Confirmed Topics and Speakers for 2018

What is needed to end HIV/AIDS?
Demetre Daskalakis, New York, USA

What we mean by ending AIDS?
Jean William Pape, Port-au-Prince, Haïti

PrEP an overview
Kenneth Mayer, Boston, USA

PrEP Implementation in STD clinics
Hugo Lopez-Gatell, Mexico City, Mexico

Early Treatment of HIV in Infants
Karin A Nielsen, Los Angeles, USA

HIV Prevention: PrEP situation in Latin American Countries
Giovanni Ravasi, Washington DC, USA

The Microbiome in HIV Infection
Sandra Pinto, Mexico City, Mexico

Treatment for Disease Resistant TB
Eduardo Gotuzzo, Lima, Peru

Dual Therapy 
Pedro Cahn, Buenos Aires, Argentina

Cost-effectiveness of Current Strategies for use in Latin America
Santiago Avila-Rios, Mexico City, Mexico

New Methods for TB Diagnosis
Rafael Lopez Olarte, Washington DC, USA

Diagnosis and Treatment of HIV Positive Women with Comorbidities
Mónica Mantilla Suárez, Bogota, Colombia

New Drugs
Daniel Kuritzkes, Boston, USA

Current Role of Integrase Inhibitors in LA Guidelines
Ernesto Martinez Buitrago, Santiago de Cali, Colombia

Experience with first-line use in Brazil
Ricardo Sobhie Diaz, São Paulo, Brazil

Adolescents
Daisy Machado, São Paulo, Brazil

Update on PEP and on its role in the era of PrEP?
Dawn Smith, Atlanta, USA

Other Sessions Under Development

The Role of Integrase Inhibitors

Latin American collaborations

Sexually Transmitted Diseases 

Treatment failure in Resource Limited settings a case based session 

Women with HIV

Vulnerable Populations

Hepatitis: Lessons learned from HIV

 

 

.